Lu Qinglai
Transaction: 04/08/2026
OTHER
Change
0
Price
Not reported
Filing
04/20/2026
Type
OTHER
Indaptus Therapeutics, Inc.
INDP • Biotechnology
$2.96
▲ +0.23 (+8.42%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$343.75M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 1.51Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:13 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.96
Change8.42%
Shares Out116.13M
Market Cap$343.75M
Enterprise Value$332.19M
52W Range0.92 - 8.57
Beta1.18
P/E-22.29
P/B30.23
P/FCF-22.64
EV/EBITDA-22.00
EV/FCF-21.88
Price$2.96
Change8.42%
Shares Out116.13M
Market Cap$343.75M
Enterprise Value$332.19M
52W Range0.92 - 8.57
Beta1.18
P/E-22.29
P/B30.23
P/FCF-22.64
EV/EBITDA-22.00
EV/FCF-21.88
Earnings Yield-4.49%
FCF Yield-4.42%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio1.51
Quick Ratio1.51
Volume332.38K
Avg Volume965.45K
EPS Surprise1.64
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
64/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 1.51Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-10-21
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
⚠ 2 high-volume insider sells detected
Dai Junyi
Transaction: 03/23/2026
OTHER
Change
0
Price
Not reported
Filing
04/02/2026
Type
OTHER
SINO LION VENTURES Ltd
Transaction: 03/23/2026
OTHER
Change
0
Price
Not reported
Filing
04/02/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Lu Qinglai | OTHER | 0 | Not reported | 04/08/2026 | 04/20/2026 |
| Dai Junyi | OTHER | 0 | Not reported | 03/23/2026 | 04/02/2026 |
| SINO LION VENTURES Ltd | OTHER | 0 | Not reported | 03/23/2026 | 04/02/2026 |
| Yao Yun | OTHER | 0 | Not reported | 03/23/2026 | 04/02/2026 |
| Lazar David E. | SELL | -700,000 | Not reported | 03/23/2026 | 03/24/2026 |
| Lazar David E. | SELL | -196,800 | Not reported | 03/23/2026 | 03/24/2026 |
| Jabbour Jerome D | OTHER | 0 | Not reported | 02/26/2026 | 02/27/2026 |
| Jabbour Jerome D | BUY | +25,000 | $2.06 | 02/26/2026 | 02/27/2026 |
| McMurdo Matthew Charles | OTHER | 0 | Not reported | 02/26/2026 | 02/26/2026 |
| Meckler Jeffrey A | SELL | -1,519 | $29.40 | 02/11/2026 | 02/13/2026 |
| Ben-Tzvi Avraham | BUY | +25,000 | Not reported | 01/20/2026 | 01/22/2026 |
| NATAN DAVID | BUY | +25,000 | $2.69 | 01/07/2026 | 01/22/2026 |
| Ben-Tzvi Avraham | BUY | +25,000 | $1.95 | 12/23/2025 | 01/22/2026 |
| NATAN DAVID | OTHER | 0 | Not reported | 01/08/2026 | 01/12/2026 |
| Linscott Walt Addison | BUY | +54,421 | $2.03 | 12/22/2025 | 12/29/2025 |
| Newman Michael James | BUY | +52,204 | $2.03 | 12/22/2025 | 12/29/2025 |
| Meckler Jeffrey A | BUY | +216,617 | $2.03 | 12/22/2025 | 12/29/2025 |
| Sassi Nir | BUY | +26,758 | $2.03 | 12/22/2025 | 12/29/2025 |
| Ben-Tzvi Avraham | OTHER | 0 | Not reported | 12/22/2025 | 12/23/2025 |
| Lazar David E. | OTHER | 0 | Not reported | 12/22/2025 | 12/23/2025 |